NCT00189410: Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours |
|
|
| Completed | 2 | 140 | Europe | Pegylated Liposomal Doxorubicin and Carboplatin | AGO Study Group, MedServ. GmbH, Wiesbaden, Essex Pharma GmbH | Cancer of the Ovary Treated as 2nd Line Therapy, Muellerian Mixed Tumours, Tumours of the Uterus, Cervical Cancers, Non-Epithelial Ovarian Tumours | 09/05 | 09/06 | | |
NCT00030472: Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix |
|
|
| Terminated | 2 | | US, Europe | pegylated liposomal doxorubicin hydrochloride | Gynecologic Oncology Group, National Cancer Institute (NCI) | Cervical Cancer | 10/06 | | | |
NCT00032162: Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer |
|
|
| Completed | 1/2 | 63 | Europe | carboplatin, pegylated liposomal doxorubicin hydrochloride | AGO Study Group | Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma | 05/05 | | | |
